Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Joseph Harvey

London
As Editor of Animal Pharm, Joseph Harvey provides news and analysis about the global animal health market across a range of species and products. He conducts exclusive interviews with the sector's biggest companies and experts, as well as start-up firms. He also hosts webinars and gives speeches on the industry.

Having gained many years' experience in business journalism, Joseph joined Informa in 2007, reporting on the medical technology space. He joined Animal Pharm, rising to become editor and taking the publication online only.

Joseph also launched a series of well-received webinars. As author of a top-selling industry report, he detailed the leading companies in the animal health sector. Since becoming editor, he has transformed Animal Pharm from just a news provider into a more in-depth analytical service.
Advertisement
Set Alert for Articles By Joseph Harvey

Latest From Joseph Harvey

Eastern European performance hurts Krka in Q1

The animal health division of Slovenian pharmaceutical company Krka returned to a dip in sales during the first quarter of 2018.

Krka Financial Results

Indianapolis tech firm to introduce 'telepresence' to veterinary sector

Hodei Technology has formed a new division to take its telepresence communications and wearable technologies to the veterinary market.

Companion Animals Food Animals

New Zealand on-farm mastitis diagnostics firm taking technology global

Mastaplex has signed up AgriHealth to distribute its point-of-care mastitis diagnostic in New Zealand, with other deals in the pipeline.

Mastitis New Zealand

Oasmia spin-off to begin US vet oncology commercialization in H2

Swedish firm Oasmia Pharmaceutical has completed the spin-off of its veterinary oncology business into a US subsidiary called AdvaVet.

United States Pharmaceuticals

Bactana secures significant portion of new equity round

US microbiome discovery firm Bactana Animal Health has received $400,000 in financing from Connecticut Innovations.

Investments Pharmaceuticals

Anizome to bridge valley of death between microbiome research and commercialization

The first company focused on a commercial therapeutic microbiome discovery platform dedicated to animal health and nutrition has been created.

Pharmaceuticals Companion Animals
See All
Advertisement
UsernamePublicRestriction

Register